ZA9880B - Table for the controlled release of active agents - Google Patents

Table for the controlled release of active agents

Info

Publication number
ZA9880B
ZA9880B ZA9880A ZA9880A ZA9880B ZA 9880 B ZA9880 B ZA 9880B ZA 9880 A ZA9880 A ZA 9880A ZA 9880 A ZA9880 A ZA 9880A ZA 9880 B ZA9880 B ZA 9880B
Authority
ZA
South Africa
Prior art keywords
active agents
controlled release
agents
release
active
Prior art date
Application number
ZA9880A
Other languages
English (en)
Inventor
Yihong Qiu
Jay S Trivedi
Sharon L Graham
Kolette M Flood
Steven L Krill
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA9880B publication Critical patent/ZA9880B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9880A 1997-01-10 1998-01-06 Table for the controlled release of active agents ZA9880B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10

Publications (1)

Publication Number Publication Date
ZA9880B true ZA9880B (en) 1998-07-08

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9880A ZA9880B (en) 1997-01-10 1998-01-06 Table for the controlled release of active agents

Country Status (8)

Country Link
US (1) US6033685A (enExample)
EP (1) EP0951279A1 (enExample)
JP (1) JP5170723B2 (enExample)
AR (1) AR010875A1 (enExample)
AU (1) AU5609998A (enExample)
CA (1) CA2277220A1 (enExample)
WO (1) WO1998030208A1 (enExample)
ZA (1) ZA9880B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
ES2399880T3 (es) * 2002-03-15 2013-04-04 Cypress Bioscience, Inc. Milnaciprán para el tratamiento del síndrome del intestino irritable
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006510639A (ja) * 2002-12-06 2006-03-30 ユセベ ファルシム ソシエテ アノニム エフレチリジン及びプソイドエフェドリンを含む錠剤
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
CA2518442A1 (en) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
SI1575565T1 (sl) * 2003-08-08 2010-04-30 Biovail Lab Int Srl Tableta bupropion hidroklorida z modificiranim sprošŽŤanjem
WO2005065673A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
KR20070043806A (ko) * 2004-07-29 2007-04-25 사노피-아벤티스 ｐＨ에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
US20080248107A1 (en) * 2005-08-24 2008-10-09 Rubicon Research Pvt. Ltd. Controlled Release Formulation
US8691272B2 (en) 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
MX2010008861A (es) * 2008-02-15 2011-02-22 Sun Pharma Advanced Res Co Ltd Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
WO2011016057A2 (en) * 2009-08-05 2011-02-10 Lupin Limited Controlled release pharmaceutical compositions of milnacipran
WO2011032139A2 (en) * 2009-09-14 2011-03-17 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
WO2011078993A1 (en) * 2009-12-21 2011-06-30 Aptapharma, Inc. Functionally-coated multilayer tablets
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
KR102600541B1 (ko) 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (enExample) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
DE69229881T2 (de) * 1991-10-04 1999-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Tablette mit verzögerter freisetzung
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Also Published As

Publication number Publication date
CA2277220A1 (en) 1998-07-16
WO1998030208A1 (en) 1998-07-16
EP0951279A1 (en) 1999-10-27
JP2001508440A (ja) 2001-06-26
US6033685A (en) 2000-03-07
JP5170723B2 (ja) 2013-03-27
AU5609998A (en) 1998-08-03
AR010875A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
ZA9880B (en) Table for the controlled release of active agents
EG22034A (en) Absorbent articles having removable components
EP1017364A4 (en) INORGANIC POLYMER COMPLEXES FOR THE CONTROLLED RELEASE OF COMPOUNDS, SPECIAL INGREDIENTS OF MEDICAMENTS
GB9826662D0 (en) Controlled release formulation
EP1048673A4 (en) INHIBITOR OF NEO VASCULARIZATION, WHICH CONTAINS DIENOGEST AS AN ACTIVE ACTIVE SUBSTANCE
SG71879A1 (en) Controlled release compositions
IL134084A0 (en) Biodegradable macromers for the controlled release of biologically active substances
IL126318A0 (en) Compounds and compositions for delivering active agents
IL126095A0 (en) Azolobenzazepine derivatives as neurogically active agents
SG71789A1 (en) Controlled release compositions
GB2310860B (en) Stable release agents
PL318586A1 (en) Combination of auxiliary components ensuring selective release of active component
IL135457A0 (en) Extended release formulation
HUP0003840A3 (en) Controlled released medical formulation
PL340305A1 (en) Composition of agents reducing the level of lipoides
ZA954368B (en) Device for the release of an active agent
AU1786799A (en) Composition for the controlled release of active compounds
GB2322867B (en) Release agent
HUP0001234A3 (en) Pharmaceutical composition for the programmed release of dexfenfluramine
EP1043331A4 (en) DIENOGEST CONTAINING OSTEORESORPTION CYTOKINE INHIBITOR AS ACTIVE INGREDIENT
GB9404544D0 (en) Controlled release formulation
GB2321185B (en) Surgical support tables
SI0804245T1 (en) Collagen preparation for the controlled release of active substances
GB9709884D0 (en) Pharmacoligically active compounds
PT993831E (pt) Compostos e composições para administrar agentes activos